Literature DB >> 27056850

[Cognitive Impairment in Patients with Bacterial Meningitis and Encephalitides].

Satoshi Kamei1.   

Abstract

Cognitive impairments, including dementia, can present as first symptoms at the acute stage, and/or as sequelae in the chronic stages, in some patients with bacterial meningitis (BM) or encephalitides. BM and encephalitides are lifethreatening neurological emergencies, and early recognition, efficient decision-making, and rapid commencement of therapy can be lifesaving. Empirical therapy should be initiated promptly whenever BM or encephalitides are a probable diagnosis. In this article cognitive impairments, including dementia, presenting in patients with BM, Herpes simplex virus encephalitis (HSVE), Human herpesvirus-6 (HHV-6) encephalitis, and Anti N-methyl-d-aspartate (NMDA) receptor encephalitis are reviewed. In the above mentioned diseases, cognitive impairment without fever might be observed at the time of disease onset. cognitive impairment has been also noted in some aged or immunocompromised patients at the onset of BM. Immediate memory disturbance as one of the first symptoms of HHV-6 encephalitis presented in 74% of patients with this disease. Cognitive impairment, including dementia as sequela, was also found in 10-27% of patients with BM, 54-69% of patients with HSVE, 33% of HHV-6 encephalitis patients, and 39% of patients with anti-NMDA receptor encephalitis. Suitable therapeutic management of these diseases at the acute stage is thus required in order to avoid these sequelae.

Entities:  

Mesh:

Year:  2016        PMID: 27056850     DOI: 10.11477/mf.1416200400

Source DB:  PubMed          Journal:  Brain Nerve        ISSN: 1881-6096


  2 in total

1.  Neuronal Damage and Neuroinflammation, a Bridge Between Bacterial Meningitis and Neurodegenerative Diseases.

Authors:  Kristine Farmen; Miguel Tofiño-Vian; Federico Iovino
Journal:  Front Cell Neurosci       Date:  2021-06-03       Impact factor: 5.505

2.  Neuroinflammation trajectories precede cognitive impairment after experimental meningitis-evidence from an in vivo PET study.

Authors:  Vijayasree V Giridharan; Allan Collodel; Jaqueline S Generoso; Giselli Scaini; Rico Wassather; Sudhakar Selvaraj; Rodrigo Hasbun; Felipe Dal-Pizzol; Fabricia Petronilho; Tatiana Barichello
Journal:  J Neuroinflammation       Date:  2020-01-04       Impact factor: 8.322

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.